RYPRX
Price
$12.23
Change
+$0.07 (+0.58%)
Updated
Jul 31 closing price
Net Assets
1.1B
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

RYPRX vs VSCIX

RYPRX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
RYPRX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYPRX is a StrongBuy and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. RYPRX (1.1B). VSCIX pays higher dividends than RYPRX: VSCIX (1.23) vs RYPRX (0.00). RYPRX was incepted earlier than VSCIX: RYPRX (35 years) vs VSCIX (29 years). RYPRX (1.22) is less costly to investors than VSCIX (0.03). RYPRX is a more actively managed with annual turnover of: 20.00 vs. VSCIX (17.00). RYPRX has a lower initial minimum investment than VSCIX: RYPRX (2000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. RYPRX (10.18). VSCIX return over 5 years is better than : 35.13 vs. RYPRX (-18.87).
RYPRXVSCIXRYPRX / VSCIX
Total Expense Ratio1.220.034,067%
Annual Report Gross Expense Ratio1.220.034,067%
Fund Existence35 years29 years-
Gain YTD18.73814.591128%
Front LoadN/AN/A-
Min. Initial Investment200050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.1B189B1%
Annual Yield % from dividends0.001.23-
Returns for 1 year10.1822.5845%
Returns for 3 years2.6643.446%
Returns for 5 years-18.8735.13-54%
Returns for 10 years-20.90156.07-13%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C